Ensuring Compliance Against Drug Diversion Act of 2021

Became Public Law No: 117-53.

Signed by President.

Presented to President.

Message on Senate action sent to the House.

Passed Senate without amendment by Unanimous Consent.

Passed/agreed to in Senate: Passed Senate without amendment by Unanimous Consent.

Senate Committee on the Judiciary discharged by Unanimous Consent. (consideration: CR S7391)

Senate Committee on the Judiciary discharged by Unanimous Consent.(consideration: CR S7391)

Received in the Senate and Read twice and referred to the Committee on the Judiciary.

Motion to reconsider laid on the table Agreed to without objection.

On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 5 (Roll no. 113). (text: 04/14/2021 CR H1764)

Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 5 (Roll no. 113).(text: 04/14/2021 CR H1764)

Considered as unfinished business. (consideration: CR H1832)

At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.

DEBATE - The House proceeded with forty minutes of debate on H.R. 1899.

Considered under suspension of the rules. (consideration: CR H1764-1765)

Mr. Pallone moved to suspend the rules and pass the bill.

Referred to the Subcommittee on Health.

Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Introduced in House